Issue |
J Extra Corpor Technol
Volume 28, Number 4, December 1996
|
|
---|---|---|
Page(s) | 191 - 198 | |
DOI | https://doi.org/10.1051/ject/1996284191 | |
Published online | 18 August 2023 |
Original Article
Evaluation of the Thrombelastograph Targeted Coagulation Assessment
Division of Clinical Perfusion Education, School of Allied Health Professions, University of Nebraska MedicalCenter, Omaha, Nebraska
* Address correspondence to: Andrew S. Bonness, BS, MT, Perfusion Services, North Iowa Mercy Health Center, 84 Beaumont Drive, Mason City, IA 50401
Extracorporeal circulation predisposes patients to hemorrhagic risk which may increase both homologous transfusion requirements and the need for pharmacological intervention. The aim of this study was to evaluate the efficacy of a new diagnostic coagulation assay utilizing the thrombelastograph (TEG).
Following Institutional Review Board approval, blood was drawn from healthy, non-medicated volunteers and four in vitro coagulopathic conditions were created, which included: hyperfibrinolysis (100% lysis), hypofibrinogenemia (<50 mg/dl), and both qualitative (1000 ug/ml nitroglycerin) and quantitative (<50 K/mm3) platelet abnormalities. Each of these four blood samples was then divided among four vials that contained known quantities of either: aminocaproic acid, fresh frozen plasma (FFP), platelet concentrate, or heparinase, and TEG profiles were completed.
Twenty-one samples were evaluated and the following results were obtained. Hyperfibrinolysis- 100% correction of fibrinolytic potential in the aminocaproic acid vial, but none in the other vials. Qualitative platelet dysfunction- significantly improved time to coagulation in the platelet vial but not in the FFP, heparinase or aminocaproic acid vials. Quantitative platelet dysfunction- no significant difference observed between any vials. Hypofibrinogenemia- significant improvement in the TEG index in the FFP vial (-2.7 ± 0.5) when compared to the aminocaproic acid ( -8.6 ± 2.5, p<.001), platelet (-6.5 ± 0.5, p<.01) and heparinase (-8.8 ± 2.5, p<.001) vials.
We conclude that this coagulation assessment assay may help in identifying the specific source of bleeding during surgeries where hyperfibrinolysis, hypofibrinogenemia, or qualitative platelet dysfunctions are present.
Key words: targeted coagulation assessment / thrombelastograph / platelet dysfunction / hyperfibrinolysis / fibrinogen
© 1996 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.